| RS2081162085 |
MLH1
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary nonpolyposis colorectal neoplasms |
| RS2081163988 |
ARID1A
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS2081169212 |
ARID1A
|
Health Risk |
Pathogenic |
Intellectual disability, autosomal dominant 14 |
| RS2081170615 |
MLH1
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary nonpolyposis colorectal neoplasms |
| RS2081171469 |
MLH1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary nonpolyposis colorectal neoplasms, Hereditary cancer-predisposing syndrome |
| RS2081171632 |
ARID1A
|
Health Risk |
Pathogenic |
Colorectal cancer, Colorectal cancer |
| RS2081172419 |
ARID1A
|
Health Risk |
Conflicting classifications of pathogenicity |
ARID1A-related disorder, ARID1A-related disorder |
| RS2081173076 |
MLH1
|
Health Risk |
Likely pathogenic |
Hereditary nonpolyposis colorectal neoplasms, Hereditary nonpolyposis colorectal neoplasms |
| RS2081174839 |
ARID1A
|
Health Risk |
Likely pathogenic |
Intellectual disability, autosomal dominant 14 |
| RS2081174999 |
ARID1A
|
Health Risk |
Likely pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS2081175768 |
ARID1A
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS2081179434 |
LAMA3
|
Health Risk |
Pathogenic |
— |
| RS2081186625 |
KCNQ2
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, 7 |
| RS2081187047 |
KCNQ2
|
Health Risk |
Likely pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS2081187692 |
KCNQ2
|
Health Risk |
Likely pathogenic |
Early-infantile DEE, Developmental and epileptic encephalopathy |
| RS2081187965 |
KCNQ2
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS2081188385 |
KCNQ2
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, 1 |
| RS2081189736 |
KCNQ2
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, 7 |
| RS2081190344 |
KCNQ2
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS2081190512 |
KCNQ2
|
Health Risk |
Pathogenic |
Intellectual disability, Early-infantile DEE |
| RS2081191454 |
KCNQ2
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 7 |
| RS2081191595 |
KCNQ2
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS2081192615 |
KCNQ2
|
Health Risk |
Conflicting classifications of pathogenicity |
Early-infantile DEE, Early-infantile DEE |
| RS2081198536 |
MCM3AP
|
Health Risk |
Pathogenic |
— |
| RS2081272792 |
MCM3AP
|
Health Risk |
Pathogenic |
— |
| RS2081272915 |
MCM3AP
|
Health Risk |
Pathogenic |
— |
| RS2081287195 |
STAT3
|
Health Risk |
Likely pathogenic |
STAT3 gain of function, Hyper-IgE recurrent infection syndrome 1 |
| RS2081288410 |
STAT3
|
Health Risk |
Likely pathogenic |
Hyper-IgE recurrent infection syndrome 1, autosomal dominant |
| RS2081300268 |
ATM
|
Health Risk |
Conflicting classifications of pathogenicity |
Ataxia-telangiectasia syndrome, Hereditary cancer-predisposing syndrome |
| RS2081303007 |
ATM
|
Health Risk |
Pathogenic/Likely pathogenic |
Ataxia-telangiectasia syndrome, Familial cancer of breast |
| RS2081303434 |
ATM
|
Health Risk |
Pathogenic |
Ataxia-telangiectasia syndrome, Hereditary cancer-predisposing syndrome |
| RS2081308163 |
ATM
|
Health Risk |
Conflicting classifications of pathogenicity |
Ataxia-telangiectasia syndrome, Hereditary cancer-predisposing syndrome |
| RS2081312339 |
ATM
|
Health Risk |
Pathogenic |
Familial cancer of breast, Hereditary cancer-predisposing syndrome |
| RS2081312935 |
MCM3AP
|
Health Risk |
Pathogenic |
— |
| RS2081314537 |
ATM
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Ataxia-telangiectasia syndrome |
| RS2081339145 |
IFT122
|
Health Risk |
Pathogenic |
Cranioectodermal dysplasia 1, Cranioectodermal dysplasia 1 |
| RS2081358317 |
KCNQ2
|
Health Risk |
Likely pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS2081358611 |
KCNQ2
|
Health Risk |
Pathogenic |
KCNQ2-related disorder, Complex neurodevelopmental disorder |
| RS2081358991 |
KCNQ2
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS2081359429 |
KCNQ2
|
Health Risk |
Pathogenic |
— |
| RS2081360507 |
PIGV
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS2081362775 |
KCNQ2
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, 7 |
| RS2081363302 |
KCNQ2
|
Health Risk |
Likely pathogenic |
Seizures, benign familial neonatal |
| RS2081363375 |
KCNQ2
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS2081363570 |
KCNQ2
|
Health Risk |
Conflicting classifications of pathogenicity |
Developmental and epileptic encephalopathy, Developmental and epileptic encephalopathy |
| RS2081369871 |
MCM3AP
|
Health Risk |
Pathogenic |
— |
| RS2081377258 |
KCNQ2
|
Health Risk |
Pathogenic |
Seizures, benign familial neonatal |
| RS2081377457 |
KCNQ2
|
Health Risk |
Likely pathogenic |
— |
| RS2081378361 |
KCNQ2
|
Health Risk |
Likely pathogenic |
— |
| RS2081378550 |
KCNQ2
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS2081381578 |
ATM
|
Health Risk |
Pathogenic/Likely pathogenic |
Ataxia-telangiectasia syndrome, Familial cancer of breast |
| RS2081381650 |
GSS
|
Health Risk |
Pathogenic/Likely pathogenic |
Glutathione synthetase deficiency with 5-oxoprolinuria, Glutathione synthetase deficiency without 5-oxoprolinuria |
| RS2081385130 |
ATM
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2081389278 |
ATM
|
Health Risk |
Pathogenic |
Ataxia-telangiectasia syndrome, Ataxia-telangiectasia syndrome |
| RS2081390223 |
MCM3AP
|
Health Risk |
association |
Autism spectrum disorder, Autism spectrum disorder |
| RS2081397580 |
ATM
|
Health Risk |
Pathogenic |
Ataxia-telangiectasia syndrome, Ataxia-telangiectasia syndrome |
| RS2081400664 |
GSS
|
Health Risk |
Likely pathogenic |
Glutathione synthetase deficiency with 5-oxoprolinuria, Glutathione synthetase deficiency with 5-oxoprolinuria |
| RS2081413206 |
LTBP4
|
Health Risk |
Conflicting classifications of pathogenicity |
Cutis laxa with severe pulmonary, gastrointestinal and urinary anomalies |
| RS2081426061 |
SYNE1
|
Health Risk |
Conflicting classifications of pathogenicity |
Emery-Dreifuss muscular dystrophy 4, autosomal dominant |
| RS2081437856 |
KCNQ2
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS2081442073 |
KCNQ2
|
Health Risk |
Likely pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS2081442293 |
KCNQ2
|
Health Risk |
Pathogenic/Likely pathogenic |
Developmental and epileptic encephalopathy, 7 |
| RS2081454038 |
LTBP4
|
Health Risk |
Likely pathogenic |
Cutis laxa with severe pulmonary, gastrointestinal and urinary anomalies |
| RS2081475505 |
MLH1
|
Health Risk |
Likely pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2081485010 |
GSS
|
Health Risk |
Likely pathogenic |
— |
| RS2081492603 |
GSS
|
Health Risk |
Pathogenic |
Glutathione synthetase deficiency with 5-oxoprolinuria, Glutathione synthetase deficiency with 5-oxoprolinuria |
| RS2081519190 |
GSS
|
Health Risk |
Conflicting classifications of pathogenicity |
Glutathione synthetase deficiency with 5-oxoprolinuria, Glutathione synthetase deficiency with 5-oxoprolinuria |
| RS2081520204 |
STAT3
|
Health Risk |
Likely pathogenic |
STAT3-related early-onset multisystem autoimmune disease, STAT3-related early-onset multisystem autoimmune disease |
| RS2081548277 |
STAT3
|
Health Risk |
Conflicting classifications of pathogenicity |
See cases, EBV-Positive Inflammatory Follicular Dendritic Cell Sarcoma |
| RS2081559622 |
LAMA3
|
Health Risk |
Pathogenic |
— |
| RS2081563738 |
UNC80
|
Health Risk |
Pathogenic |
Hypotonia, infantile |
| RS2081575204 |
ATM
|
Health Risk |
Pathogenic |
Familial cancer of breast, Hereditary cancer-predisposing syndrome |
| RS2081578007 |
ATM
|
Health Risk |
Conflicting classifications of pathogenicity |
Ataxia-telangiectasia syndrome, Hereditary cancer-predisposing syndrome |
| RS2081592972 |
LTBP4
|
Health Risk |
Likely pathogenic |
Cutis laxa with severe pulmonary, gastrointestinal and urinary anomalies |
| RS2081593717 |
TLK2
|
Health Risk |
Pathogenic |
— |
| RS2081636353 |
ATM
|
Health Risk |
Conflicting classifications of pathogenicity |
Ataxia-telangiectasia syndrome, Hereditary cancer-predisposing syndrome |
| RS2081637337 |
ATM
|
Health Risk |
Likely pathogenic |
Ataxia-telangiectasia syndrome, Ataxia-telangiectasia syndrome |
| RS2081638052 |
LTBP4
|
Health Risk |
Pathogenic |
— |
| RS2081639925 |
ATM
|
Health Risk |
Conflicting classifications of pathogenicity |
Ataxia-telangiectasia syndrome, Hereditary cancer-predisposing syndrome |
| RS2081640268 |
ATM
|
Health Risk |
Pathogenic |
Ataxia-telangiectasia syndrome, Ataxia-telangiectasia syndrome |
| RS2081646501 |
ATM
|
Health Risk |
Likely pathogenic |
Ataxia-telangiectasia syndrome, Familial cancer of breast |
| RS2081656681 |
ATM
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial cancer of breast, Hereditary cancer-predisposing syndrome |
| RS2081657007 |
ATM
|
Health Risk |
Likely pathogenic |
Ataxia-telangiectasia syndrome, Familial cancer of breast |
| RS2081660483 |
ATM
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Ataxia-telangiectasia syndrome |
| RS2081660777 |
ATM
|
Health Risk |
Pathogenic |
Ataxia-telangiectasia syndrome, Hereditary cancer-predisposing syndrome |
| RS2081667850 |
ATM
|
Health Risk |
Pathogenic/Likely pathogenic |
Ataxia-telangiectasia syndrome, Hereditary cancer-predisposing syndrome |
| RS2081712040 |
STAT3
|
Health Risk |
Likely pathogenic |
STAT3-related early-onset multisystem autoimmune disease, STAT3-related early-onset multisystem autoimmune disease |
| RS2081714489 |
MLH1
|
Health Risk |
Likely pathogenic |
Lynch syndrome 1, Lynch syndrome 1 |
| RS2081811652 |
PRMT7
|
Health Risk |
Pathogenic |
— |
| RS2081828234 |
TRAIP
|
Health Risk |
Pathogenic |
— |
| RS2081852478 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Cardiovascular phenotype |
| RS2081878770 |
TTN
|
Health Risk |
Likely pathogenic |
Cardiomyopathy, Cardiomyopathy |
| RS2081903545 |
STAT3
|
Health Risk |
Pathogenic |
Hyper-IgE recurrent infection syndrome 1, autosomal dominant |
| RS2081905517 |
STAT3
|
Health Risk |
Likely pathogenic |
Hyper-IgE recurrent infection syndrome 1, autosomal dominant |
| RS2081922847 |
MLH1
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary nonpolyposis colorectal neoplasms, Breast carcinoma |
| RS2081930857 |
MLH1
|
Health Risk |
Pathogenic |
Lynch-like syndrome, Lynch-like syndrome |
| RS2081940708 |
ROBO1
|
Health Risk |
Conflicting classifications of pathogenicity |
Pituitary stalk interruption syndrome, Pituitary hormone deficiency |
| RS2082011693 |
PRODH
|
Health Risk |
Likely pathogenic |
Schizophrenia 4, Proline dehydrogenase deficiency |
| RS2082047976 |
HYDIN
|
Health Risk |
Likely pathogenic |
— |
| RS2082048690 |
MLH1
|
Health Risk |
Pathogenic |
Lynch-like syndrome, Lynch-like syndrome |